AAAAAA

   
Results: 1-16 |
Results: 16
Acupuncture: Evidence and implications for cancer supportive care
Authors: Shen, J Glaspy, J
Citation: J. Shen et J. Glaspy, Acupuncture: Evidence and implications for cancer supportive care, CANCER PRAC, 9(3), 2001, pp. 147-150
Methodological issues in trials of acupuncture - Reply
Authors: Shen, J Wenger, N Glaspy, J Hays, RD Albert, PS Choi, C Shekelle, PG
Citation: J. Shen et al., Methodological issues in trials of acupuncture - Reply, J AM MED A, 285(8), 2001, pp. 1016-1016
Anemia and fatigue in cancer patients
Authors: Glaspy, J
Citation: J. Glaspy, Anemia and fatigue in cancer patients, CANCER, 92(6), 2001, pp. 1719-1724
Improving the standard of care in the management of cancer-related anaemia: focus on darbepoetin alfa, a novel erythropoiesis stimulating protein - Introduction
Authors: Glaspy, J
Citation: J. Glaspy, Improving the standard of care in the management of cancer-related anaemia: focus on darbepoetin alfa, a novel erythropoiesis stimulating protein - Introduction, BR J CANC, 84, 2001, pp. 1-2
A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy
Authors: Glaspy, J Jadeja, JS Justice, G Kessler, J Richards, D Schwartzberg, L Rigas, J Kuter, D Harmon, D Prow, D Demetri, G Gordon, D Arseneau, J Saven, A Hynes, H Boccia, R O'Byrne, J Colowick, AB
Citation: J. Glaspy et al., A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy, BR J CANC, 84, 2001, pp. 17-23
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer
Authors: Smith, RE Jaiyesimi, IA Meza, LA Tchekmedyian, N Chan, D Griffith, H Brosman, S Bukowski, R Murdock, M Rarick, M Saven, A Colowick, AB Fleishman, A Gayko, U Glaspy, J
Citation: Re. Smith et al., Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer, BR J CANC, 84, 2001, pp. 24-30
Thrombocytopenia caused by the development of antibodies to thrombopoietin
Authors: Li, JZ Yang, C Xia, YP Bertino, A Glaspy, J Roberts, M Kuter, DJ
Citation: Jz. Li et al., Thrombocytopenia caused by the development of antibodies to thrombopoietin, BLOOD, 98(12), 2001, pp. 3241-3248
Status of high-dose chemotherapy for breast cancer: A review
Authors: Nieto, Y Champlin, RE Wingard, JR Vredenburgh, JJ Elias, AD Richardson, PR Glaspy, J Jones, RB Stiff, PJ Bearman, SI Cagnoni, PJ McSweeney, PA LeMaistre, CF Pecora, AL Shpall, EJ
Citation: Y. Nieto et al., Status of high-dose chemotherapy for breast cancer: A review, BIOL BLOOD, 6(5), 2000, pp. 476-495
High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: Experience in California
Authors: Damon, LE Hu, WW Stockerl-Goldstein, KE Blume, KG Wolf, JL Gold, E Cecchi, GR Irwin, D Glaspy, J Territo, M Miller, W Mason, JR Linker, CA
Citation: Le. Damon et al., High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: Experience in California, BIOL BLOOD, 6(5), 2000, pp. 496-505
Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation
Authors: Bolwell, B Vredenburgh, J Overmoyer, B Gilbert, C Chap, L Menchaca, DM Cruickshank, S Glaspy, J
Citation: B. Bolwell et al., Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation, BONE MAR TR, 26(2), 2000, pp. 141-145
Electroacupuncture for control of myeloablative chemotherapy-induced emesis - A randomized controlled trial
Authors: Shen, JN Wenger, N Glaspy, J Hays, RD Albert, PS Choi, C Shekelle, PG
Citation: Jn. Shen et al., Electroacupuncture for control of myeloablative chemotherapy-induced emesis - A randomized controlled trial, J AM MED A, 284(21), 2000, pp. 2755-2761
Optimal hemoglobin levels for cancer patients - Discussion
Authors: Glaspy, J Harper, P
Citation: J. Glaspy et P. Harper, Optimal hemoglobin levels for cancer patients - Discussion, SEMIN ONCOL, 27(2), 2000, pp. 16-17
Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy
Authors: Crawford, J Tomita, DK Mazanet, R Glaspy, J Ozer, H
Citation: J. Crawford et al., Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy, CYTOK CELL, 5(4), 1999, pp. 187-193
Role of iron in optimizing responses of anemic cancer patients to erythropoietin
Authors: Glaspy, J Cavill, I
Citation: J. Glaspy et I. Cavill, Role of iron in optimizing responses of anemic cancer patients to erythropoietin, ONCOLOGY-NY, 13(4), 1999, pp. 461-473
Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone
Authors: Franklin, WA Glaspy, J Pflaumer, SM Jones, RB Hami, L Martinez, C Murphy, JR Shpall, EJ
Citation: Wa. Franklin et al., Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone, BLOOD, 94(1), 1999, pp. 340-347
Ex vivo expansion and differentiation of unselected peripheral blood progenitor cells in serum-free media
Authors: Paquette, RL Gonzalez, E Yoshimura, R Tran, L Choi, R Baldwin, G Slamon, DJ Glaspy, J
Citation: Rl. Paquette et al., Ex vivo expansion and differentiation of unselected peripheral blood progenitor cells in serum-free media, J HEMATOTH, 7(6), 1998, pp. 481-491
Risultati: 1-16 |